Le Lézard
Classified in: Health
Subjects: NPT, EXE, DIS, AVO

Blind Maryland Voters to Protest Segregated Ballots


BALTIMORE, June 11, 2018 /PRNewswire-USNewswire/ --

National Federation of the Blind logo (PRNewsFoto/National Federation of the Blind)

Event: Informational Protest

Date: June 14, 2018

Time: 11:00 a.m. ? 1:00 p.m.

Place: Southeast Anchor Library
3601 Eastern Avenue 
Baltimore, MD 21224

Attention political, state government, community news, and education editors:

The members of the National Federation of the Blind of Maryland (NFBMD), the state's largest organization of blind Marylanders, along with other disability rights organizations will hold an informational protest to highlight the Maryland State Board of Election's continued segregation of ballots cast by blind and other voters with disabilities.

Many blind and disabled voters must use the Election Systems and Software (ES&S) ExpressVote Ballot Marking Device (BMD) to cast their ballots. This machine produces a paper ballot that is smaller in size and different in content from the ballot that is hand marked by voters who do not need an accessible voting system. Therefore, ballots cast by disabled voters are no longer secret. For more information visit: http://nfbmd.org/node/232

About the National Federation of the Blind of Maryland
The National Federation of the Blind of Maryland (NFBMD), an affiliate of the National Federation of the Blind, is an organization that believes in the full capacity of blind people, and has the power, influence, diversity and determination to help transform our dreams into reality. Learn more about our many programs and initiatives at www.nfbmd.org.

CONTACT:
Sharon Maneki, President
National Federation of the Blind of Maryland
(410) 241-9012 (Cell)
[email protected]

SOURCE National Federation of the Blind


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: